Li-ESWT treatment reduces inflammation, oxidative stress, and pain via the PI3K/AKT/FOXO1 pathway in autoimmune prostatitis rat models.

Bin FengZhilong DongYiran WangGuanghui YanEnguang YangHui ChengChaozhao LiangZongyao HaoXiansheng ZhangZhengyao SongZhancheng JiangMing ChenZhongjin YueZhiping Wang

Published in: Andrology (2021)

Li-ESWT may reduce inflammation, oxidative stress, and pain in rats with autoimmunity-induced prostatitis via the PI3 K/AKT/FOXO1 pathway. It implies that Li-ESWT can present a potential therapeutic option for the treatment of CP/CPPS.

Keyphrases

oxidative stress
diabetic rats
chronic pain
dna damage
transcription factor
pain management
induced apoptosis
signaling pathway
ion batteries
neuropathic pain
multiple sclerosis
pi k akt
cell proliferation
solid state
smoking cessation